Chiral Synthesis of (2S,3S)-2-(2-Morpholin-2-yl-2-phenylmethoxy)phenol

Chirality

Volumn 16, Issue 3, 2004, Pages 168-173

  Prabhakaran, Jaya ^a   Majo, Vattoly J ^a   Mann, J John ^a   Kumar, J S Dileep ^a  

^a NYSPI/Columbia University ^*  (United States)

Author keywords

Chiral synthesis; Imaging probes; Mandelic acid; Reboxetine; Resolution

Indexed keywords

2 (2 MORPHOLIN 2 YL 2 PHENYLMETHOXY)PHENOL; 2 [ALPHA (2 ETHOXYPHENOXY)PHENYLMETHYL]MORPHOLINE; 2 [ALPHA (2 METHOXYPHENOXY)PHENYLMETHYL]MORPHOLINE; LEWIS ACID; MANDELIC ACID; NORADRENALIN UPTAKE INHIBITOR; PHENOL DERIVATIVE; REBOXETINE; TOLUENESULFONIC ACID; TOLUENESULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; MELTING POINT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REACTION ANALYSIS; RING OPENING; STRUCTURE ACTIVITY RELATION;

ANTIDEPRESSIVE AGENTS; DRUG DESIGN; METHODS; MOLECULAR STRUCTURE; MORPHOLINES; NEUROTRANSMITTER UPTAKE INHIBITORS; STEREOISOMERISM;

EID: 1542336744     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/chir.20004     Document Type: Article

References (24)

1. Melloni P, Tore AD, Lazzari E, Mazzini G, Alberto B, Matilde B, Ottorino X, Sante R, Alessandro RC. Potential antidepressant agents. α -Aryloxy-benzyl derivatives of ethanolamine and morpholine. Eur J Med Chem 1984;19:235-242.
2. Marcio M. Reboxetine, the first selective noradrenaline reuptake inhibitor antidepressant: efficacy and tolerability in 2613 patients. Int J Psychiatry Clin Pract 2000;4:201-208.
3. Montgomery SA, Schatzberg AF. Introduction. Reboxetine: a new selective antidepressant for the treatment of depression. J Clin Psychiatry 1998;59:143.
4. Wong EHF, Sonders MS, Amara SG, Tinholt PM, Piercey MFP, Hoffmann WP, Hyslop DK, Franklin S, Porsolt RD, Bonsignori A, Carfagna N, McArthur RA. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol Psychiatry 2000;47:818-829.
5. Cocchiara G, Battaglia R, Pevarello P, Benedetti MS. Comparison of the disposition and of the metabolic pattern of reboxetine, a new antidepressant, in the rat, dog, monkey and man. Eur J Drug Metab Pharmacokinet 1991;16:231-239.
6. Method for the preparation of aryl ethers. Eur Pat Appl. 2003; EP 1308443.
7. Melloni P, Tore AD, Lazzari E, Mazzini G, Alessandro R. Substituted propanolamine and morpholine derivatives. Ger Offen 1979; DE 2901032-19790802.
8. Melloni P, Tore AD, Lazzari E, Mazzini G, Meroni M. Configurational studies on 2-[α-(2-ethoxy-phenoxy)benzyl]morpholine FCE 20124. Tetrahedron 1985;41:1393-1399.
9. Walters RR, Susan BC. Improved enantioselective method for the determination of the enantiomers of reboxetine in plasma by solid-phase extraction, chiral derivatization, and column-switching high-performance liquid chromatography with fluorescence detection. J Chromatogr A 1998;828:167-176.
10. Frigerio E, Pianezzola E, Benedetti SM. Sensitive procedure for the determination of reboxetine enantiomers in human plasma by reversed-phase high-performance liquid chromatography with fluorimetric detection after chiral derivatization with (+)-1-(9-fluorenyl) ethyl chloroformate. J Chromatogr A 1994;660:351-358.
11. Maria RA, Roberto M, Cesare S, Carlo P, Giuseppe C, Salvatore F. Separation of reboxetine enantiomers by means of capillary electrophoresis. Electrophoresis 2002;23:1870-1877.
12. Ficarra R, Calabro ML, Tommasini S, Melardi S, Cutroneo P, Ficarra P. Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases. Chromatographia 2001;53:261-265.
13. Wilson AA, Patrick JD, Mozley DH, Doug GN, Nobrega J, Garcia A, Meyer J, Houle S. Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter. Nucl Med Biol 2003;30:85-92.
14. Lin KS, Ding Y-S. Synthesis and evaluation of a new norepinephrine transporter PET ligand in non-human primates. 15th International Symposium on Radiopharmaceuticals, Sydney, Australia; 2003: S-58.
15. a) Schou M, Hallidin C, Pike VW, Sovago J, Gulyas B, Shchukin E, Mozley D, Dobson D, Johnson DP, Innis R, Farde L. Preparation and PET evaluation of [18F]FMPBM-D2 - a promising brain norepinephrine transporter (NET) radioligand. 15th International Symposium on Radiopharmaceuticals, Sydney, Australia; 2003: S-59.
16. 11C]MeNR. Nucl Med Biol 2003;30:707-714.
17. Oussaid M, Thach L, Loupy A. Selective dealkylation of alkyl aryl ethers in heterogeneous basic media under microwave irradiation. Tetrahedron Lett 1997;38:2451-2454.
18. Gerrard W, Lappert MF. Reaction of borontrichloride with organic compounds. Chem Rev 1958;58:1081-1111.
19. Burwell RL. The cleavage of ethers. Chem Rev 1954;54:615-685.
20. Olah GA, Subhash CN, Gupta BGB, Malhotra R. Synthetic methods and reactions: transformations with chlorotrimethylsilane/sodiumidodie a convenient in situ iodotrimethylsilane reagent. J Org Chem 1979;44:1247-1250.
21. Bungard CJ, Morris JC. An efficient preparation of 6-alkoxy substituted benzocyclobutenones. Synthesis 2001;5:741-744.
22. Boehlow TR, Harburn J, Spilling CD. Approaches to the synthesis of some tyrosine derived marine sponge metabolites. J Org Chem 2001;66:3111-3118.
23. Ueki M, Amemiya M. Removal of 9-fluorenylmehtyl oxycarbonyl (FMOC) group with TBAF. Tetrahedron Lett 1987;28:6617-6620.
24. Ohman D, Norlander B, Peterson C, Bengtsson F. Simultaneous determination of reboxetine and O-desethylreboxetine enantiomers using enantioselective reversed-phase high-performance liquid chromatography. J Chromatogr A 2002;947:247-254.